CAMK2 Researchers from Across the Globe
Danielle Veenma, M.D.
A clinical geneticist and physician–scientist at Erasmus Medical Center in Rotterdam whose work includes describing and interpreting CAMK2-related neurodevelopmental disorders through detailed patient phenotyping and genotype–phenotype correlation.
Geeske van Woerden, Ph.D.
A neuroscientist at Erasmus University Medical Center in Rotterdam—where she studies how disease-causing CAMK2 gene variants disrupt brain development and synaptic function.
Meg Stratton, Ph.D.
A researcher at UMass who studies how CaMKII’s unique molecular properties enable synapse formation, maintenance, and long-term memory.
Leslie Griffin, Ph.D.
A researcher at Brandeis University whose lab studies how neuronal activity and behavior are shaped by experience, focusing on calcium signaling and CaMKII-mediated pathways.
Howard Schulman, M.D., Ph.D.
A biochemist and neuroscientist (formerly from Rutgers University) whose work has been foundational in defining the structure, regulation, and role of CaMKII in synaptic plasticity, long‑term potentiation, and memory at the molecular level.
Rob Tombes, Ph.D.
Researcher at Virginia Commonwealth University exploring the role of CaMKII in vertebrate development using zebrafish to study CAMKII.
Haruhiko Bito, M.D., Ph.D.
Neuroscientist from University of Toyko known for his research on calcium signaling and calmodulin-dependent kinases, including CAMKII, and their roles in synaptic plasticity, neuronal gene regulation, and memory.
